Welcome to our dedicated page for FTAAW news (Ticker: FTAAW), a resource for investors and traders seeking the latest updates and insights on FTAAW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FTAAW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FTAAW's position in the market.
FTAC Athena Acquisition Corp. announced its intention to dissolve and liquidate as it failed to complete an initial business combination within the required time frame. Effective February 24, 2023, the company will redeem all outstanding Class A ordinary shares at approximately $10.17 per share. The shares will be cancelled post-redemption, with holders receiving their pro rata share from the trust account. The company's sponsors have waived their redemption rights. Following dissolution, the company plans to delist its securities from Nasdaq and file Form 15 to terminate securities registration under the Securities Exchange Act of 1934.
FTAC Athena Acquisition Corp. (NASDAQ:FTAA) announced the cancellation of its extraordinary general meeting, originally scheduled for February 15, 2023. This decision comes after the Company chose to withdraw proposals from its Definitive Proxy Statement filed on January 30, 2023. The cancellation signifies a strategic move as the Company focuses on its upcoming annual general meeting, aiming to streamline shareholder engagement and decision-making processes.
FTAC Athena Acquisition Corp. (NASDAQ:FTAA) announced receipt of a notice from Nasdaq due to its failure to timely file its Quarterly Report on Form 10-Q for the period ending March 31, 2021. This non-compliance with Nasdaq Listing Rule 5250(c)(1) does not impact the trading of its units, Class A ordinary shares, or warrants. The Company must submit a compliance plan by July 26, 2021, to regain adherence to the listing rule, with a potential extension up to 180 days if accepted. The delay is attributed to the evaluation process related to accounting for warrants issued by SPACs.
FTAC Athena Acquisition Corp. (NASDAQ: FTAAU) announced that holders of its units can start trading Class A ordinary shares and warrants separately from April 16, 2021. The units not separated will continue to trade under the symbol FTAAU, while the Class A shares and warrants will trade under FTAA and FTAAW, respectively. This decision follows the effective registration statement by the SEC on February 22, 2021. Cantor Fitzgerald & Co. is the sole book-running manager for the offering. The announcement highlights the company's efforts to enhance trading flexibility for investors.
FTAC Athena Acquisition Corp. (NASDAQ:FTAAU) has completed its initial public offering (IPO) of 25 million units at $10.00 each, raising gross proceeds of $250 million. The units began trading on NASDAQ on February 23, 2021, and include one Class A ordinary share and one-fourth of a warrant. Whole warrants will trade under the symbol FTAAW, while Class A shares will trade under FTAA once separated. Cantor Fitzgerald acted as the sole book-running manager for this offering, with the registration statement declared effective on February 22, 2021.
FTAC Athena Acquisition Corp. (NASDAQ: FTAAU) announced the pricing of its initial public offering (IPO) on February 22, 2021. The company will issue 22,000,000 units at $10.00 each, generating gross proceeds of $220,000,000. These units will start trading on the Nasdaq Capital Market on February 23, 2021. Each unit consists of one Class A ordinary share and one-fourth of a warrant, exercisable for one share at $11.50. The offering is expected to close around February 25, 2021, pending customary conditions. Cantor Fitzgerald & Co. is the sole book-running manager for the offering.
